Correlation Between Genovis AB and Organoclick

Can any of the company-specific risk be diversified away by investing in both Genovis AB and Organoclick at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genovis AB and Organoclick into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Genovis AB and Organoclick AB, you can compare the effects of market volatilities on Genovis AB and Organoclick and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genovis AB with a short position of Organoclick. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genovis AB and Organoclick.

Diversification Opportunities for Genovis AB and Organoclick

-0.44

Correlation Coefficient

Genovis AB  Organoclick

Very good diversification

The 3 months correlation between Genovis and Organoclick is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Genovis AB and Organoclick AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organoclick AB and Genovis AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genovis AB are associated (or correlated) with Organoclick. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organoclick AB has no effect on the direction of Genovis AB i.e., Genovis AB and Organoclick go up and down completely randomly.

Pair Corralation between Genovis AB and Organoclick

Assuming the 90 days trading horizon Genovis AB is expected to under-perform the Organoclick. But the stock apears to be less risky and, when comparing its historical volatility, Genovis AB is 1.3 times less risky than Organoclick. The stock trades about -0.2 of its potential returns per unit of risk. The Organoclick AB is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  260.00  in Organoclick AB on September 24, 2024 and sell it today you would earn a total of  15.00  from holding Organoclick AB or generate 5.77% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	95.45%
Values	Daily Returns

Genovis AB  vs.  Organoclick AB

Genovis AB

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Genovis AB are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Genovis AB may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Organoclick AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Organoclick AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Genovis AB and Organoclick

The main advantage of trading using opposite Genovis AB and Organoclick positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genovis AB position performs unexpectedly, Organoclick can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organoclick will offset losses from the drop in Organoclick's long position.

The idea behind Genovis AB and Organoclick AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.